These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21192233)

  • 21. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
    AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.
    Reekie J; Mocroft A; Ledergerber B; Beniowski M; Clotet B; van Lunzen J; Chiesi A; Pradier C; Machala L; Lundgren JD;
    HIV Med; 2010 Aug; 11(7):469-78. PubMed ID: 20201975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?
    Bagchi S; Kempf MC; Westfall AO; Maherya A; Willig J; Saag MS
    Clin Infect Dis; 2007 Jan; 44(1):135-8. PubMed ID: 17143829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.
    Burgard M; Boufassa F; Viard JP; Garrigue I; Ruffault A; Izopet J; Vabret A; Descamps D; Colson P; Seigneurin JM; Rouzioux C;
    AIDS; 2009 Oct; 23(16):2165-71. PubMed ID: 19657270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study.
    Poggensee G; Kücherer C; Werning J; Somogyi S; Bieniek B; Dupke S; Jessen H; Hamouda O;
    HIV Med; 2007 Nov; 8(8):511-9. PubMed ID: 17944684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa.
    Hamers RL; Sigaloff KC; Kityo C; Mugyenyi P; de Wit TF
    Curr Opin HIV AIDS; 2013 Jan; 8(1):19-26. PubMed ID: 23143140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of drug resistance on viral load in patients failing antiretroviral therapy.
    Machouf N; Thomas R; Nguyen VK; Trottier B; Boulassel MR; Wainberg MA; Routy JP
    J Med Virol; 2006 May; 78(5):608-13. PubMed ID: 16555280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Laboratory testing including CD4 T-cell count and determination of viral load to evaluate the impact of first line antiretroviral treatment at 6 months in adults in Benin].
    Ogouyemi-Hounto A; Zannou D; Metodakou D; Lafia B; Gomez V; Akinocho E
    Med Trop (Mars); 2010 Feb; 70(1):100. PubMed ID: 20337131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa.
    Wouters E; Van Damme W; van Rensburg D; Meulemans H
    AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit of viral load testing for confirmation of immunological failure in HIV patients treated in rural Malawi.
    Kanapathipillai R; McGuire M; Mogha R; Szumilin E; Heinzelmann A; Pujades-Rodríguez M
    Trop Med Int Health; 2011 Dec; 16(12):1495-500. PubMed ID: 21883726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment.
    Barth RE; Tempelman HA; Smelt E; Wensing AM; Hoepelman AI; Geelen SP
    Pediatr Infect Dis J; 2011 Jan; 30(1):52-6. PubMed ID: 20631647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.